Evidence map›Paper›PMID 41930704›Full record

ArticleTechnology in cancer research & treatment

Fully Automated Stain Quantification Framework for IHC Whole Slide Images in Breast Cancer.

Tuo Yin, Frédéric Lifrange, Zoë Denis, Alex de Caluwé, Laurence Buisseret, Xavier Catteau, Clara Legros, Nick Reynaert, Jennifer Dhont

Abstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tuo YinRadiophysics and MRI Physics Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID 0000-0002-8778-480X
Frédéric LifrangeInstitute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
Zoë DenisBreast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Alex de CaluwéDepartment of Radiotherapy, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Laurence BuisseretBreast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.
Xavier CatteauLaboratoire CurePath (CHIREC, CHU Tivoli), Charleroi, Belgium.
Clara LegrosLaboratoire CurePath (CHIREC, CHU Tivoli), Charleroi, Belgium.
Nick ReynaertRadiophysics and MRI Physics Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Jennifer DhontRadiophysics and MRI Physics Laboratory, Université Libre de Bruxelles (ULB), Brussels, Belgium.ORCID 0000-0003-1296-4627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionImmunohistochemistry (IHC) plays a crucial role in breast cancer diagnosis, treatment selection, and research. However, manual scoring of IHC whole slide images (WSIs) is time-consuming and suffers from inter- and intra-observer variability.MethodsTo help address these challenges, we present and publicly release a fully automated, compartment-specific (ie, tumor and stroma) H-scoring framework for IHC analysis. The framework consists of three deep learning modules: tumor-stroma segmentation, nuclei segmentation, and H-score estimation for tumor and stroma. It processes WSIs in minutes, delivering consistent and reproducible H-scores with accuracy comparable to expert pathologists. The modular design also allows flexibility for use in other IHC tasks such as cellularity quantification, and supports configuration options to balance accuracy and computational efficiency.ResultsFine-tuned on 87 expert-annotated patches, the framework achieved a Spearman's rank correlation (

Indexed as

Breast NeoplasmsImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedImmunohistochemistryAutomationBiomarkers, TumorDeep LearningFemaleHumansObserver VariationReproducibility of ResultsStaining and LabelingBiomarkers, Tumorbreast cancercomputational pathologydeep learningH-scoreimmunohistochemistry

Identifiers

PMID41930704
PMCPMC13051182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.